A convergent stereoselective synthesis of the potent anti-inflammatory, proresolving and neuroprotective lipid mediator protectin D1 (2) has been achieved in 15% yield over eight steps. The key features were a stereocontrolled Evans-aldol reaction with Nagao's chiral auxiliary and a highly selective Lindlar reduction of internal alkyne 23, allowing the sensitive conjugated E,E,Z-triene to be introduced late in the preparation of 2. The UV and LC/MS-MS data of synthetic protectin D1 (2) matched those obtained from endogenously produced material.
Introduction
Polyunsaturated fatty acids (PUFAs), such as docosahexaenoic acid (1, DHA), play a major role in the physiology of living organisms. 1 Recent efforts by the Serhan research group have established that DHA (1) is a substrate for the biosynthesis of several potent anti-inflammatory proresolving mediators, such as protectin D1 (2), 2 maresin 1, 3 resolvin D1 and resolvin D3. 2a,4 All of these compounds have enabled new research areas related to many disease states associated with inflammation. 5 It was reported that protectin D1 (2) is biosynthesized from DHA (1) via a lipoxygenase-mediated pathway that converts 1 by 15-lipoxygenase (15-LO) to the 17S-hydroperoxide intermediate (3), which is rapidly converted into the 16,17-epoxide (4), followed by enzymatic hydrolysis to the antiinflammatory and proresolving oxygenated lipid 2 (Fig. 1) . 6 This compound has been reported to exhibit strong in vivo protective activity in several inflammatory 6 as well as many other disease models. [7] [8] [9] [10] For example, the oxygenated polyunsaturated fatty acid 2 protects the retina and the brain from oxidative stress with very potent agonist activities. 7 It is noteworthy that 2 was observed to be several orders of magnitude more potent in vivo than its precursor DHA. 2c Moreover, additional biological effects have recently been reported for this C22-oxygenated metabolite. 11 Hence, protectin D1 (2) is very interesting as a lead compound for the development of potential new anti-inflammatory drugs. 12 The prefix neuro is added when this oxygenated PUFA is formed by neural tissues. 2a As of today, two syntheses of protectin D1 (2) have appeared. 6, 13 In connection with our interest in the synthesis of biologically active PUFA-derived natural products, 14 as well as the many interesting biological activities of protectin D1 (2), we decided to prepare the DHA derived product 2. A common structural feature for several of the lipid mediators isolated by the Serhan group 2-4 is the chemically unstable E,E,Z-triene connected to either one or two secondary allylic alcohols. In the retrosynthetic analysis of 2, Fig. 2 , the aldehyde 6 is a key intermediate. nium-1-sulfonate (14) was treated with aqueous potassium hydroxide at −20°C to yield glutaconaldehyde potassium salt 15 that was transformed further with the Br 2 /PPh 3 complex to (2E,4E)-5-bromopenta-2,4-dienal (8) in 41% yield over the two steps. This sensitive aldehyde was then reacted with thiazolidinone 9a, developed by Nagao and co-workers, 17 4 and CuI using diethyl amine as a solvent. This afforded the bis-hydroxyl-protected methyl ester 22 in 95% yield. Deprotection of the two TBS-groups in 22 was achieved with an excess of five equivalents of TBAF in THF at 0°C to afford 81% yield of the diol 23. 24 The internal conjugated alkyne in 23 was reduced to the methyl ester 24 in 65% yield after chromatographic purification on silica. A modified Lindlar hydrogenation reaction 25 produced triene 24 with high stereoselectivity, while the diimide reduction 26 or the standard Lindlar hydrogenation reaction 27 of 23 failed to give a high conversion to 24. The Boland reduction 28 gave in our hands a large amount of elimination of water from 23. Finally, lenient saponification of the methyl ester 24 at 0°C with dilute aqueous LiOH in methanol followed by mild acidic work-up (aqueous NaH 2 PO 4 ) afforded a 78% yield of protectin D1 (2) in the last step (Scheme 3). The chemical purity of synthetic 2 and 24 was determined to be >95% and >98%, respectively, by HPLC analyses (see ESI †). The UV spectrum of synthetic protectin D1 (2) showed absorbance peaks (λ MeOH max ) at 262, 271 and 282 nm, which is in excellent agreement with the literature. 6 In order to obtain evidence that synthetic 2 and 24 matched that of authentic protectin D1 (2), protectin D1 (2) was obtained from endogenous murine self-resolving exudates. 29 Fig. 3 shows that the synthetic 2 was matched with endogenously produced 2.
In Fig. 3A authentic protectin D1 (2) obtained in vivo from exudates is displayed amongst its stereoisomers. 30 Fig . 3B shows the chromatographic behaviour of endogenously produced 2 (T R = 13.2 min) and Fig. 3C demonstrates that synthetic 2 co-elutes with endogenous 2. In addition, the MS-MS spectra for both biosynthesized 2 and synthetic 2 displayed essentially identical MS-MS fragmentation spectra with the following fragments assigned: . Similar results were also obtained when synthetic ester 24 was hydrolysed to the acid 2 and compared with authentic protectin D1 (2). The chromatographic properties of synthetic 2 and the free acid of 24, the latter obtained by hydrolysis with aqueous LiOH in THF, 6 were matched with data of endogenously formed protectin D1 (2). These results demonstrated that hydrolyzed 24 co-elutes with authentic 2. Furthermore, the MS-MS spectra for both the free acid obtained from 24 and biosynthesized 2 displayed essentially identical MS-MS fragmentation spectra (see ESI †). Our NMR spectral data of synthetic 2 were in accord with those published by Petasis, Serhan and co-workers, 13b but not with the spectra published by others. 13a 
Conclusions
In summary, the potent endogenously produced lipid mediator protectin D1 (2) was prepared in eight steps and in 15% yield from the known aldehyde 8 in a convergent manner. Our synthesis of 2 compares well with those previously reported with respect to yields and simplicity, affording multimg quantities of this potent and biologically interesting natural product. The synthetic material displayed identical chromatographic properties with endogenously produced protectin D1 (2). Further in vivo biological studies are ongoing and will be reported elsewhere. (R,4E,6E)-7-Bromo-3-hydroxy-1-((S)-4-isopropyl-2-thioxothia-zolidin-3-yl)hepta-4,6-dien-1-one (16a)
The (R)-aldol product 16a was prepared in 86% yield from dienal 8 and the auxiliary 9a according to the procedure of Olivo and coworkers. 19a The diastereomeric ratio (15 
(R,4E,6E)-7-Bromo-3-((tert-butyldimethylsilyl)oxy)-1-((S)-4-isopropyl-2-thioxothiazolidin-3-yl)hepta-4,6-dien-1-one (17)
According to the procedure of Corey and coworkers, 31 Methyl (R,4Z,7Z,11E,13E)-14-bromo-10-((tert-butyldimethylsilyl)oxy)tetradeca-4,7,11,13-tetraenoate (21) To the Wittig salt 7 (581 mg, 1.04 mmol, 1.0 equiv.) in THF (9.5 mL) was added mol. sieves and HMPA (1.5 mL) before NaHMDS (0.6 M in toluene, 1.0 equiv.) was slowly added at −78°C and then stirred for 5 min at 0°C. Aldehyde 6 ( prepared from DIBAL-H reduction of 17 as described above) was added at −78°C. The solution was allowed to slowly warm up to room temperature in the dry ice/acetone bath for 24 h before it was quenched with phosphate buffer (10 mL, pH = 7.2). Et 2 O (15 mL) was added and the phases were separated. The aqueous phase was extracted with Et 2 O (2 × 15 mL) and the combined organic layers were dried (Na 2 SO 4 ), before it was concentrated in vacuo. 
Synthesis of protectin D1 (2)
Methyl ester 24 (18 mg, 0.032 mmol) was dissolved in methanol-water 1 : 1 (30 mL) and cooled to 0°C. LiOH (1.0 M, 1.9 mL) was added dropwise. The reaction mixture was stirred at the above-mentioned temperature for 48 h, after which a saturated solution of NaH 2 PO 4 (4.0 mL) was added. Next, NaCl (10.0 g) was added followed by EtOAc (50 ml). The organic phase was decanted, dried (Na 2 SO 4 ), and concentrated in vacuo affording the title compound 2 (14 mg, 78%) as a colourless oil. The chemical purity (>95%) was determined by HPLC analysis (Eclipse XDB-C18, MeOH-3.3 mM HCOOH in H 2 O, 7 : 3, 1.0 mL min −1 ): t r (minor) = 9.97 min and t r (major) = 
